For me, the most interesting part was the Q & A - lots of good information, and the enthusiasm of the presenters was palpable. Still, important to keep in mind that it's still early days.

One fascinating tidbit was a mention of a large study that looked at the correlation between humira (and similar anti-inflammatory monoclonal antibodies) use, and incidence of alzheimer's. According to Cuong Do, CEO of Bivi, this study found that patients who had been prescribed humira, et al, were 50% less likely to develop alzheimer's than were patients who were not taking these anti-inflammatories.